Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Mariana V, Machado"'
Publikováno v:
GE: Portuguese Journal of Gastroenterology, Pp 1-8 (2021)
Introduction: Lifestyle changes are the mainstay treatment of nonalcoholic fatty liver disease (NAFLD). We aimed to assess the magnitude of weight loss in a group of NAFLD patients followed on a combined lifestyle intervention by a multidisciplinary
Externí odkaz:
https://doaj.org/article/87803a00bd29439ea77eb4b21c0bde65
Autor:
Vanda Marques, Marta B. Afonso, Nina Bierig, Filipa Duarte-Ramos, Álvaro Santos-Laso, Raul Jimenez-Agüero, Emma Eizaguirre, Luis Bujanda, Maria J. Pareja, Rita Luís, Adília Costa, Mariana V. Machado, Cristina Alonso, Enara Arretxe, José M. Alustiza, Marcin Krawczyk, Frank Lammert, Dina G. Tiniakos, Bertram Flehmig, Helena Cortez-Pinto, Jesus M. Banales, Rui E. Castro, Andrea Normann, Cecília M. P. Rodrigues
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease where liver biopsy remains the gold standard for diagnosis. Here we aimed to evaluate the role of circulating adiponectin, leptin, and insulin-like growth f
Externí odkaz:
https://doaj.org/article/68eb6a3e3a264deeb15761ad0b8acf14
Publikováno v:
Liver Transplantation. 29:431-448
Publikováno v:
European Journal of Gastroenterology & Hepatology. 33:e883-e897
Frailty and sarcopenia associate with increased mortality in patients with liver cirrhosis on the transplant waitlist. We conducted a systematic review on the impact of pretransplant frailty and sarcopenia on post-transplant outcomes in adult patient
Publikováno v:
Annals of Hepatology, Vol 11, Iss 4, Pp 440-449 (2012)
Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance the extraction of energy from diet and regulate whole-bod
Externí odkaz:
https://doaj.org/article/f3c8a28ecd6c46bc8a837a16b711ce96
Autor:
S. Policarpo, Jorge Luiz Albuquerque Coutinho, Armando Carvalho, Isabel Medeiros, Francisco Velasco, Ana Catarina Alves, Mafalda Bourbon, Mariana V. Machado, Helena Cortez-Pinto, Sofia Carvalhana, Jorge Leitão, Ana P. Silva
Publikováno v:
Obesity Surgery. 30:560-568
Introduction: Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of adiposopathy. Recently, a new score was developed to estimate body fat percentage (relative fat mass, RFM). We aimed to evaluate the value of RFM in predicting the p
Autor:
Cecília M. P. Rodrigues, Helena Cortez-Pinto, Marta B. Afonso, Mariana V. Machado, Margarida Gama-Carvalho, André L. Simão, Pedro Rodrigues, Rui E. Castro
Publikováno v:
Journal of Molecular Medicine. 97:1113-1126
Non-alcoholic fatty liver disease (NAFLD) pathogenesis associates with intramyocellular lipid deposition and mitochondrial dysfunction. microRNAs (miRs), including pro-apoptotic miR-34a, are modulated during disease progression in liver tissue and pl
Autor:
Helena Cortez‐Pinto, Rodrigo Liberal, Susana Lopes, Mariana V. Machado, Joana Carvalho, Teresa Dias, Arsénio Santos, Cláudia Agostinho, Pedro Figueiredo, Rafaela Loureiro, Alexandra Martins, Gonçalo Alexandrino, Isabel Cotrim, Carina Leal, José Presa, Mónica Mesquita, Joana Nunes, Catarina Gouveia, Ana Horta e Vale, Ana Luísa Alves, Mariana Coelho, Luís Maia, Isabel Pedroto, António Banhudo, João Sebastião Pinto, Marta Vargas Gomes, Joana Oliveira, Valeska Andreozzi, Filipe Calinas, null on behalf of Liver.pt
Publikováno v:
United European Gastroenterology Journal
Background The current standard of treatment in primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), although a considerable proportion of patients show incomplete response resulting in disease progression. Objective This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1508633955dd84b747ca78c45e2492b7
https://hdl.handle.net/10451/56460
https://hdl.handle.net/10451/56460
Publikováno v:
Annals of Hepatology, Vol 17, Iss 4, Pp 547-560 (2018)
Decompensated liver cirrhosis has a dismal prognosis, with an overall survival of 2-4 years, which is worse than for many oncological diseases. Albumin is an important tool in the management of patients with cirrhosis, since it decreases for less tha
Autor:
Carlos Freitas, Joana Carvalho, Paula Moura dos Santos, Luís Carrilho-Ribeiro, Ana Valente, Rui Tato Marinho, Mariana V. Machado, Cilénia Baldaia
Publikováno v:
Gastroenterología y Hepatología. 42:552-554